Angiogenic and osteogenic potential of bone repair cells for craniofacial regeneration

Tissue Engineering - Part A

Volumn 16, Issue 9, 2010, Pages 2809-2820

  Kaigler, Darnell ^a   Pagni, Giorgio ^a   Park, Chan Ho ^a   Tarle, Susan A ^a   Bartel, Ronnda L ^b   Giannobile, William V ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b Aastrom Biosciences Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; ENDOTHELIAL CELLS; FLOW CYTOMETRY; PHOSPHATASES; POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; ANGIOGENIC CELLS; AUTOMATED CELL; BONE ENGINEERING; BONE MARROW; BONE REPAIR; CELL POPULATIONS; CLINICAL APPLICATION; CRANIOFACIAL; EX-VIVO; EXPRESSION LEVELS; FLUORESCENT LABELING; IN-VITRO; MINERALIZED BONE; OSTEOGENIC; OSTEOGENIC DIFFERENTIATION; OSTEOGENIC POTENTIAL; REVERSE TRANSCRIPTASE- POLYMERASE CHAIN REACTION; THERAPEUTIC POTENTIALS; TISSUE ENGINEERING APPLICATIONS; TUBE-LIKE; VON KOSSA STAINING;

BONE;

ALKALINE PHOSPHATASE;

ANGIOGENESIS; ARTICLE; BONE DEVELOPMENT; BONE MARROW CELL; CELL CULTURE; CELL DIFFERENTIATION; CYTOLOGY; FACIAL BONE; FLOW CYTOMETRY; HUMAN; JAW; METABOLISM; METHODOLOGY; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

ALKALINE PHOSPHATASE; BONE MARROW CELLS; CELL DIFFERENTIATION; CELLS, CULTURED; FACIAL BONES; FLOW CYTOMETRY; HUMANS; JAW; NEOVASCULARIZATION, PHYSIOLOGIC; OSTEOGENESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ENGINEERING;

EID: 77956075817     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2010.0079     Document Type: Article

References (41)

1. Langer, R., and Vacanti, J.P. Tissue engineering. Science 260, 920, 1993.
2. Alsberg, E., Hill, E.E., and Mooney, D.J. Craniofacial tissue engineering. Crit Rev Oral Biol Med 12, 64, 2001.
3. Kaigler, D., Cirelli, J.A., and Giannobile, W.V. Growth factor delivery for oral and periodontal tissue engineering. Expert Opin Drug Deliv 3, 647, 2006.
4. Shi, S., Bartold, P.M., Miura, M., Seo, B.M., Robey, P.G., and Gronthos, S. The efficacy of mesenchymal stem cells to regenerate and repair dental structures. Orthod Craniofac Res 8, 191, 2005.
5. Krebsbach, P.H., Kuznetsov, S.A., Satomura, K., Emmons, R.V., Rowe, D.W., and Robey, P.G. Bone formation in vivo: comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 63, 1059, 1997.
6. Friedenstein, A.J., Ivanov-Smolenski, A.A., Chajlakjan, R.K., Gorskaya, U.F., Kuralesova, A.I., Latzinik, N.W., and Ger-asimow, U.W. Origin of bone marrow stromal mechanocytes in radiochimeras and heterotopic transplants. Exp Hematol 6, 440, 1978.
7. Ishaug-Riley, S.L., Okun, L.E., Prado, G., Applegate, M.A., and Ratcliffe, A. Human articular chondrocyte adhesion and proliferation on synthetic biodegradable polymer films. Biomaterials 20, 2245, 1999.
8. Chang, F., Ishii, T., Yanai, T., Mishima, H., Akaogi, H., Ogawa, T., and Ochiai, N. Repair of large full-thickness articular cartilage defects by transplantation of autologous uncultured bone-marrow-derived mononuclear cells. J Or-thop Res 26, 18, 2008.
9. Marcacci, M., Kon, E., Moukhachev, V., Lavroukov, A., Kutepov, S., Quarto, R., Mastrogiacomo, M., and Cancedda, R. Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng 13, 947, 2007.
10. Faundez, A.A., Taylor, S., and Kaelin, A.J. Instrumented fusion of thoracolumbar fracture with type I mineralized collagen matrix combined with autogenous bone marrow as a bone graft substitute: a four-case report. Eur Spine J 15 Suppl 5, 630, 2006.
11. Gimbel, M., Ashley, R.K., Sisodia, M., Gabbay, J.S., Wasson, K.L., Heller, J., Wilson, L., Kawamoto, H.K., and Bradley, J.P. Repair of alveolar cleft defects: reduced morbidity with bone marrow stem cells in a resorbable matrix. J Craniofac Surg 18, 895, 2007.
12. Ueda, M., Yamada, Y., Kagami, H., and Hibi, H. Injectable bone applied for ridge augmentation and dental implant placement: human progress study. Implant Dent 17, 82, 2008.
13. Velardi, F., Amante, P.R., Caniglia, M., De Rossi, G., Gaglini, P., Isacchi, G., Palma, P., Procaccini, E., and Zinno, F. Os-teogenesis induced by autologous bone marrow cells transplant in the pediatric skull. Childs Nerv Syst 22, 1158, 2006.
14. Soltan, M., Smiler, D., and Choi, J.H. Bone marrow: orchestrated cells, cytokines, and growth factors for bone regeneration. Implant Dent 18, 132, 2009.
15. Gerber, H.P., Vu, T.H., Ryan, A.M., Kowalski, J., Werb, Z., and Ferrara, N. VEGF couples hypertrophic cartilage remodeling, ossification and angiogenesis during endochon-dral bone formation. Nat Med 5, 623, 1999.
16. Kaigler, D., Krebsbach, P.H., Wang, Z., West, E.R., Horger, K., and Mooney, D.J. Transplanted endothelial cells enhance orthotopic bone regeneration. J Dent Res 85, 633, 2006.
17. Grellier, M., Granja, P.L., Fricain, J.C., Bidarra, S.J., Renard, M., Bareille, R., Bourget, C., Amedee, J., and Barbosa, M.A. The effect of the co-immobilization of human osteoprogenitors and endothelial cells within alginate microspheres on mineralization in a bone defect. Biomaterials 30, 3271, 2009.
18. Kim, S.S., Park, M.S., Cho, S.W., Kang, S.W., Ahn, K.M., Lee, J.H., and Kim, B.S. Enhanced bone formation by marrow-derived endothelial and osteogenic cell transplantation. J Biomed Mater Res A 92, 246, 2010.
19. Moioli, E.K., Clark, P.A., Chen, M., Dennis, J.E., Erickson, H.P., Gerson, S.L., and Mao, J.J. Synergistic actions of he-matopoietic and mesenchymal stem/progenitor cells in vascularizing bioengineered tissues. PLoS ONE 3, e3922, 2008.
20. Schwartz, R.M., Palsson, B.O., and Emerson, S.G. Rapid medium perfusion rate significantly increases the productivity and longevity of human bone marrow cultures. Proc Natl Acad Sci USA 88, 6760, 1991.
21. Caldwell, J., Palsson, B.O., Locey, B., and Emerson, S.G. Culture perfusion schedules influence the metabolic activity and granulocyte-macrophage colony-stimulating factor production rates of human bone marrow stromal cells. J Cell Physiol 147, 344, 1991.
22. Stiff, P., Chen, B., Franklin, W., Oldenberg, D., Hsi, E., Bayer, R., Shpall, E., Douville, J., Mandalam, R., Malhotra, D., Muller, T., Armstrong, R.D., and Smith, A. Autologous transplantation of ex vivo expanded bone marrow cells grown from small aliquots after high-dose chemotherapy for breast cancer. Blood 95, 2169, 2000.
23. Pecora, A.L., Stiff, P., LeMaistre, C.F., Bayer, R., Bachier, C., Goldberg, S.L., Parthasarathy, M., Jennis, A.A., Smith, A.K., Douville, J., Chen, B., Armstrong, R.D., Mandalam, R.K., and Preti, R. A phase II trial evaluating the safety and effectiveness of the AastromReplicell system for augmentation of low-dose blood stem cell transplantation. Bone Marrow Transplant 28, 295, 2001.
24. Whyte, M.P., Kurtzberg, J., McAlister, W.H., Mumm, S., Podgornik, M.N., Coburn, S.P., Ryan, L.M., Miller, C.R., Gottesman, G.S., Smith, A.K., Douville, J., Waters-Pick, B., Armstrong, R.D., and Martin, P.L. Marrow cell transplantation for infantile hypophosphatasia. J Bone Miner Res 18, 624, 2003.
25. Jaroscak, J., Goltry, K., Smith, A., Waters-Pick, B., Martin, P.L., Driscoll, T.A., Howrey, R., Chao, N., Douville, J., Bur-hop, S., Fu, P., and Kurtzberg, J. Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the Aas-tromReplicell System. Blood 101, 5061, 2003.
26. Dennis, J.E., Esterly, K., Awadallah, A., Parrish, C.R., Poynter, G.M., and Goltry, K.L. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration. Stem Cells 25, 2575, 2007.
27. Krebsbach, P.H., and Robey, P.G. Dental and skeletal stem cells: potential cellular therapeutics for craniofacial regeneration. J Dent Educ 66, 766, 2002.
28. Pittenger, M.F., Mackay, A.M., Beck, S.C., Jaiswal, R.K., Douglas, R., Mosca, J.D., Moorman, M.A., Simonetti, D.W., Craig, S., and Marshak, D.R. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143, 1999.
29. Manolagas, S.C., Burton, D.W., and Deftos, L.J. 1,25-Dihy-droxyvitamin D3 stimulates the alkaline phosphatase activity of osteoblast-like cells. J Biol Chem 256, 7115, 1981.
30. Park, C.H., Abramson, Z.R., Taba, M., Jr., Jin, Q., Chang, J., Kreider, J.M., Goldstein, S.A., and Giannobile, W.V. Three-dimensional micro-computed tomographic imaging of alveolar bone in experimental bone loss or repair. J Period-ontol 78, 273, 2007.
31. Kaigler, D., Krebsbach, P.H., Polverini, P.J., and Mooney, D.J. Role of vascular endothelial growth factor in bone marrow stromal cell modulation of endothelial cells. Tissue Eng 9, 95, 2003.
32. Nor, J.E., Christensen, J., Mooney, D.J., and Polverini, P.J. Vascular endothelial growth factor (VEGF)-mediated an-giogenesis is associated with enhanced endothelial cell survival and induction of Bcl-2 expression. Am J Pathol 154, 375, 1999.
33. Folkman, J., and Haudenschild, C. Angiogenesis in vitro. Nature 288, 551, 1980.
34. Voyta, J.C., Via, D.P., Butterfield, C.E., and Zetter, B.R. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J Cell Biol 99, 2034, 1984.
35. Gastens, M.H., Goltry, K., Prohaska, W., Tschope, D., Stratmann, B., Lammers, D., Kirana, S., Gotting, C., and Kleesiek, K. Good manufacturing practice-compliant expansion of marrow-derived stem and progenitor cells for cell therapy. Cell Transplant 16, 685, 2007.
36. Haynesworth, S.E., Baber, M.A., and Caplan, A.I. Cell surface antigens on human marrow-derived mesenchymal cells are detected by monoclonal antibodies. Bone 13, 69, 1992.
37. Fonsatti, E., and Maio, M. Highlights on endoglin (CD105): from basic findings towards clinical applications in human cancer. J Transl Med 2, 18, 2004.
38. Boiret, N., Rapatel, C., Boisgard, S., Charrier, S., Tchirkov, A., Bresson, C., Camilleri, L., Berger, J., Guillouard, L., Guerin, J.J., Pigeon, P., Chassagne, J., and Berger, M.G. CD34\+CDw90(Thy-1)\+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells. Exp Hematol 31, 1275, 2003.
39. Meijer, G.J., de Bruijn, J.D., Koole, R., and van Blitterswijk, C.A. Cell based bone tissue engineering in jaw defects. Biomaterials 29, 3053, 2008.
40. Caplan, A.I. Mesenchymal stem cells. J Orthop Res 9, 641, 1991.
41. Goshima, J., Goldberg, V.M., and Caplan, A.I. The osteo-genic potential of culture expanded rat marrow mesenchy-mal cells assayed in vivo in calcium phosphate ceramic blocks. Clin Orthop Relat Res 262, 298, 1991.